Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: BUD stock price vs DGX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DGX's multiple
Needs DGX P/E.
Implied fair value · at BUD's multiple
Needs BUD P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
13 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Anheuser-Busch InBev SA/NV · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Quest Diagnostics Inc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MOLSON COORS BEVERAGE CO
BUD vs TAP
BOSTON BEER CO INC
BUD vs SAM
CONSTELLATION BRANDS, INC.
BUD vs STZ
Celsius Holdings, Inc.
BUD vs CELH
Tilray Brands, Inc.
BUD vs TLRY
ABBOTT LABORATORIES
BUD vs ABT
DANAHER CORP /DE/
BUD vs DHR
THERMO FISHER SCIENTIFIC INC.
BUD vs TMO
HCA Healthcare, Inc.
BUD vs HCA
LABCORP HOLDINGS INC.
BUD vs LH
WEST PHARMACEUTICAL SERVICES INC
BUD vs WST
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
